Financial Insights and Market Strategies in Medical Imaging

► Get a free share!

This show is sponsored by Trading 212! To get free fractional shares worth up to 100 EUR / GBP, you can open an account with Trading 212 through this link https://www.trading212.com/Jdsfj/FTSE. Terms apply.

When investing, your capital is at risk and you may get back less than invested.

Past performance doesn’t guarantee future results.

► Get 15% OFF Finchat.io:

Huge thanks to our sponsor, FinChat.io, the best investing toolkit we've discovered! Get 15% off your subscription with code below and unlock powerful tools to analyze stocks, discover hidden gems, and build income streams. Check them out at FinChat.io!

https://finchat.io/playingftse/?lmref=iQl2VQ

► Episode Notes:

What has Steve D done this week? Find out on this week’s PlayingFTSE Show!

The FTSE 100 is up, the S&P 500 is down. But what have the Steves done?

Again it’s a mixture of new and old and some new shares for the watch list. And we’re really excited about some of the things we’ve been finding.

Nvidia put up another strong result, but the market seemed uninspired. The stock dropped significantly, despite impressive growth in sales and profits. 

With the next Blackwell already on the way, the shares are now trading at a forward P/E of 21. Is that low enough for one of the Steves to take an interest?

Celebrus Technologies is a new stock for us. But Steve W has been looking at it and he very much likes what he sees.

It’s got good recurring revenues, a price tag that doesn’t look too bad – and even a dividend! But will being listed in the UK count against it with investors?

Who needs Amazon as a customer? Not Progyny – the reproductive assistance stock has shrugged off the loss of a big customer.

It’s a setback, but revenues are still growing and the outlook for the company is largely the same (just a year behind). The share price rose then fell – quickly – so is this time to buy?

Rolls-Royce is now well past Covid-19 recovery. But the company is still posting strong growth and it’s offering impressive guidance for the next few years. 

The stock climbed 20% on the news, meaning there’s a lot priced in. But there are also lots of growth avenues…  

Steve D has been looking at Lantheus - a promising healthcare company . It’s a stock that’s been working higher over the last few years but there could be more to come.

Pylarify is the thing investors are typing into Google. But there’s a lot more in the pipeline for them to be taking note of over the next few years.

Only on this week’s PlayingFTSE Podcast!

► Support the show:

Appreciate the show and want to offer your support? You could always buy us a coffee at: https://ko-fi.com/playingftse

(All proceeds reinvested into the show and not to coffee!)

There are many ways to help support the show, liking, commenting and sharing our episodes with friends! You can also check out our clothing merch store: https://playingftse.teemill.com/

We get a small cut of anything you buy which will be reinvested back into the show...

► Timestamps:

0:00 INTRO & OUR WEEKS

6:36 NVIDIA EARNINGS

20:45 CELEBRUS

31:09 PROGYNY

42:18 ROLLS ROYCE

51:21 LANTHEUS

► Show Notes:

What’s been going on in the financial world and why should anyone care? Find out as we dive into the latest news and try to figure out what any of it means. We talk about stocks, markets, politics, and loads of other things in a way that’s accessible, light-hearted and (we hope) entertaining. For the people who know nothing, by the people who know even less. Enjoy

► Wanna get in contact?

Got a question for us? Drop it in the comments below or reach out to us on Twitter: https://twitter.com/playingftseshow

Or on Instagram: https://www.instagram.com/playing_ftse/

► Enquiries:

Please email - playingftsepodcast@gmail(dot)com

► Disclaimer:

This information is for entertainment purposes only and does not constitute financial advice. Always consult with a qualified financial professional before making any investment decisions.